Literature DB >> 25445090

Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin.

Ruifeng Liu1, Yong Wang2, Xincheng Zhao1, Yuanwen Yang1, Kaiming Zhang1.   

Abstract

BACKGROUND: Psoriasis is a chronic inflammatory skin disorder associated with a host of immune abnormalities. Mesenchymal stem cells (MSCs) have immunosuppressive properties and, in earlier studies, we found that the bone marrow MSCs of patients with psoriasis exhibit abnormal cytokine secretion. Since MSCs can be isolated from skin, we hypothesized that the biological characteristics of MSCs in psoriatic skin lesions might reflect the pathogenesis of psoriasis.
OBJECTIVE: To investigate the effects of MSCs from psoriatic skin lesions on T-cell proliferation.
MATERIALS AND METHODS: MSCs obtained from psoriatic skin lesions and healthy human skin were examined by flow cytometry and cell differentiation assays. MSCs were co-cultured with normal peripheral blood T cells to assess changes in T-cell proliferation. Concentrations of interleukin (IL)-6, IL-11, hepatocyte growth factor (HGF), and transforming growth factor (TGF)-β1 in the MSC culture supernatants were measured by enzyme-linked immunosorbent assays.
RESULTS: Surface markers and differentiation capacity were similar in MSCs from both sources. MSCs in psoriatic skin lesions were weaker inhibitors of T-cell proliferation (p<0.05) and exhibited increased secretion of IL-11 and reduced secretion of IL-6 and HGF (p<0.05). Secretion of TGF-β1 was unchanged (p > 0.05).
CONCLUSION: This study demonstrated abnormalities in MSCs derived from psoriatic skin lesions. We suggest that the attenuated inhibitory effect on T-cell proliferation might be one of the pathogenic mechanisms of psoriasis.

Entities:  

Keywords:  immunosuppression; mesenchymal stem cells; psoriasis; skin lesions

Mesh:

Substances:

Year:  2014        PMID: 25445090     DOI: 10.1684/ejd.2014.2394

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  15 in total

Review 1.  Novel drug delivery strategies and gene therapy regimen as a promising perspective for management of psoriasis.

Authors:  Sujata Pralhad Sawarkar; Vijay Yadav
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 May-Jun       Impact factor: 2.545

Review 2.  The emerging roles of circular RNAs in regulating the fate of stem cells.

Authors:  Ziyao Zhuang; Lingfei Jia; Weiran Li; Yunfei Zheng
Journal:  Mol Cell Biochem       Date:  2020-09-11       Impact factor: 3.396

3.  Indirect co-cultures of healthy mesenchymal stem cells restore the physiological phenotypical profile of psoriatic mesenchymal stem cells.

Authors:  A Campanati; M Orciani; G Sorgentoni; V Consales; M Mattioli Belmonte; R Di Primio; A Offidani
Journal:  Clin Exp Immunol       Date:  2018-05-31       Impact factor: 4.330

4.  Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from Bone Marrow and Skin.

Authors:  Ruifeng Liu; Wenjuan Chang; Hong Wei; Kaiming Zhang
Journal:  Stem Cells Int       Date:  2016-04-27       Impact factor: 5.443

Review 5.  Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action.

Authors:  Tae-Hoon Shin; Hyung-Sik Kim; Soon Won Choi; Kyung-Sun Kang
Journal:  Int J Mol Sci       Date:  2017-01-25       Impact factor: 5.923

6.  Human umbilical cord blood-derived mesenchymal stem cells ameliorate psoriasis-like skin inflammation in mice.

Authors:  Yun Sang Lee; Shyam Kishor Sah; Ji Hyun Lee; Kwang-Won Seo; Kyung-Sun Kang; Tae-Yoon Kim
Journal:  Biochem Biophys Rep       Date:  2016-10-08

7.  Variances in the mRNA expression profile of TGF-β1-3 isoforms and its TGF-βRI-III receptors during cyclosporin a treatment of psoriatic patients.

Authors:  Anna Michalska-Bańkowska; Dominika Wcisło-Dziadecka; Beniamin Grabarek; Ligia Brzezińska-Wcisło; Urszula Mazurek; Natalia Salwowska; Mirosław Bańkowski
Journal:  Postepy Dermatol Alergol       Date:  2018-07-19       Impact factor: 1.837

Review 8.  Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives.

Authors:  Anna Campanati; Veronica Consales; Monia Orciani; Katia Giuliodori; Giulia Ganzetti; Ivan Bobyr; Giulia Sorgentoni; Roberto di Primio; Annamaria Offidani
Journal:  Psoriasis (Auckl)       Date:  2017-11-27

Review 9.  Stem Cells as Potential Candidates for Psoriasis Cell-Replacement Therapy.

Authors:  Agnieszka Owczarczyk-Saczonek; Magdalena Krajewska-Włodarczyk; Anna Kruszewska; Waldemar Placek; Wojciech Maksymowicz; Joanna Wojtkiewicz
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

10.  Mesenchymal Stromal Cells from the Epidermis and Dermis of Psoriasis Patients: Morphology, Immunophenotype, Differentiation Patterns, and Regulation of T Cell Proliferation.

Authors:  M E Castro-Manrreza; L Bonifaz; O Castro-Escamilla; A Monroy-García; A Cortés-Morales; E Hernández-Estévez; J Hernández-Cristino; H Mayani; J J Montesinos
Journal:  Stem Cells Int       Date:  2019-12-01       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.